1-6 of 6
Authors: John C Woolcott
Save search
Sort by
Journal Article

Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program

PDF
Gary R Lichtenstein and others
Inflammatory Bowel Diseases, izae308, https://doi.org/10.1093/ibd/izae308
Published: 04 April 2025
Journal Article

Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program

PDF
Bruce E Sands and others
Inflammatory Bowel Diseases, izaf036, https://doi.org/10.1093/ibd/izaf036
Published: 28 February 2025
Journal Article

The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program

PDF
Vipul Jairath and others
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 923–934, https://doi.org/10.1093/ibd/izae111
Published: 20 June 2024
Journal Article

An Insight into Patients’ Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts

PDF
David T Rubin and others
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1748–1758, https://doi.org/10.1093/ibd/izad247
Published: 02 November 2023
Journal Article

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program

PDF
Edward V Loftus and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 744–751, https://doi.org/10.1093/ibd/izac139
Published: 06 July 2022
Journal Article

Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis

PDF
William J Sandborn and others
Inflammatory Bowel Diseases, Volume 28, Issue 9, September 2022, Pages 1338–1347, https://doi.org/10.1093/ibd/izab278
Published: 27 December 2021